Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.

导出 LinkOut

翻译打印收藏纠错

作者： Manthan,Kathrotiya ^[1] ; Vivek,Radhakrishnan ^[1] ; Saurabh J,Bhave ^[1] ; Arijit,Nag ^[1] ; Neeraj,Arora ^[2] ; Mita,Roychoudhry ^[3] ; Mayur,Parihar ^[2] ; Deepak,Mishra ^[2] ; Reena,Nair ^[1] ; Mammen,Chandy ^[1] ; Jeevan,Kumar ^[1]

作者单位： Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India. ^[1] Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India. ^[2] Department of Clinical Hematology and HCT, Nursing Division, Tata Medical Center, Kolkata, West Bengal, India. ^[3]

主题词人类(Humans);造血干细胞移植(Hematopoietic Stem Cell Transplantation);多发性骨髓瘤(Multiple Myeloma);回顾性研究(Retrospective Studies)

DOI 10.4103/ijc.ijc_78_22

PMID 38258869

发布时间 2024-02-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交